Looking for a Trasylol lawyer in District of Columbia? Get in touch with one of our Trasylol lawyers in District of Columbia now.
Home : Unsafe Drugs : Trasylol : MSN Newsfeeds
Trasylol - MSN Newsfeeds
- Bloomberg - Trasylol, an anti-bleeding drug that was pulled off the market last year by Germany's biggest drugmaker, is safe when used during a certain type of cardiac surgery, researchers said. Centrotherm Photovoltaics AG (CTN GY) jumped 3.56 euros ...
- HealthCentral.com - The drug, approved in 1993 and known generically as aprotinin, is designed to prevent blood loss in patients with an increased risk for blood loss during heart bypass surgery. In their study of nearly 10,000 patients who had heart surgery between 2000 ...
- Bloomberg - Feb. 8 (Bloomberg) -- Bayer AG's Trasylol, an anti-bleeding drug that was pulled off the market last year, is safe when used during a certain type of cardiac surgery, researchers said. The drug didn't hold extra risks when given in operations using a ...
- Reuters - LONDON, Feb 8 (Reuters) - Bayer AG's (BAYG.DE: Quote , Profile , Research ) anti-bleeding drug Trasylol appears safe in certain heart procedures, according to a study suggesting the treatment linked to kidney damage -- and even death -- poses little ...
- BusinessWeek - THURSDAY, Feb. 7 (HealthDay News) -- While use of the clotting drug aprotinin (Trasylol) appears safe during on-pump cardiac surgeries, combining it with angiotensin-converting enzyme (ACE) inhibitors during off-pump cardiac surgery shows a ...
- BlackNews.com - Aprotinin - The front page of a September 2006 New York Times newspaper reported that the FDA issued a warning that this antifibrinolytic drug who’s manufacturer is ...
- The Ledger - The drug, known generically as aprotinin, has had F.D.A. approval since 1993. Two weeks ago, researchers from the Ottawa Health Research Institute stopped a study of Trasylol in 3,000 heart bypass and valve surgery patients because although ...
- Calgary Sun - It was designed to test the drug aprotinin — marketed as Trasylol by Bayer Inc. — against other drugs used to reduce blood loss during heart bypass surgery. The FDA statement says that compared to the other drugs ...
- Medical News Today - It does not contain aprotinin, which has been associated with adverse health effects. EVICEL™ is easy to use and readily available for time-sensitive needs in the operating room. The product is sold as a frozen liquid and requires less than one ...
- Medical News Today - It does not contain aprotinin, which has been associated with adverse health effects. EVICEL(TM) is easy to use and readily available for time-sensitive needs in the operating room. The product is sold as a frozen liquid and requires less than one ...
- PR Newswire - LEVERKUSEN, Germany and WEST HAVEN, Conn., Nov. 5 /PRNewswire/ -- Following consultation with the German Federal Institute for Drugs and Medical Devices (BfArM), the U.S. Food and Drug Administration (FDA), Health Canada, and other health authorities ...
- First Coast News - The announcement came as a Canadian study comparing the safety and efficacy of the drug, Trasylol, with two others was halted. Preliminary results from that trial also suggested Trasylol increased the risk of death when compared with the other drugs ...
- WOAI - Trasylol, also known as aprotinin, works by blocking enzymes that dissolve blood clots. It is designed to stem blood loss and enable patients receiving heart bypass surgery to avoid transfusions. Bayer estimates Trasylol has been used in roughly 4.8 ...
- Orlando Sentinel - Bayer AG halted worldwide sales Monday of its anti-bleeding drug Trasylol at the request of U.S. and foreign health officials pending further analysis of a Canadian study that suggests it is linked to a 50 percent higher risk of death than the other ...
- Orlando Sentinel - Bayer AG halted worldwide sales Monday of its anti-bleeding drug Trasylol at the request of U.S. and foreign health officials pending further analysis of a Canadian study that suggests it is linked to a 50 percent higher risk of death than the other ...
- San Francisco Examiner - There is a more recent article version. 21 days ago Bayer Halts Sales of Anti-Bleeding Drug 21 days ago Bayer Stops Sales of Trasylol Globally 21 days ago Bayer Halts Sale of Trasylol Globally 21 days ago » Bayer Suspends Sales of Trasylol « 21 ...
- San Francisco Examiner - Trasylol, also known as aprotinin, works by blocking enzymes that dissolve blood clots. There are not many treatment options for patients at risk for excessive bleeding during cardiac surgery, the FDA noted in its announcement. The agency said it was ...
- San Francisco Examiner - This is the most recent article version. 18 days ago » Bayer Halts Sales of Anti-Bleeding Drug « 18 days ago Bayer Stops Sales of Trasylol Globally 18 days ago Bayer Halts Sale of Trasylol Globally 18 days ago Bayer Suspends Sales of Trasylol 18 ...
- Xagena Medical News - Data Safety Monitoring Board’s ( DSMB ) has recommended to stop patient enrollment in the Aprotinin ( marketed as Trasylol ) treatment group arm of the: BART ( Blood conservation using antifibrinolytics: A randomized trial in a cardiac surgery ...
- PhysOrg - ... kidney cancer, and represents one of Bayer's biggest commercial hopes, with sales in the first half of 2007 of 107 million euros (157 million dollars). On November 5, Bayer said it was suspending global sales of an anti-bleeding treatment, Trasylol ...
Looking for a Trasylol lawyer in District of Columbia? Get in touch with one of our Trasylol lawyers in District of Columbia now.
Pages: 1 2 3 4 5 6 ... Next
